Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Musculoskeletal tissue engineering: Adipose derived stromal cell implementation for the treatment of osteoarthritis.

Biomaterials·2022

Same author

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Journal of dental research·2018

Same author

Hair on the Index Finger.

The Indian medical gazette·2017

Same author

Stem and progenitor cells: advancing bone tissue engineering.

Drug delivery and translational research·2015

Same author

Impact of surgical innovation on tissue repair in the surgical patient.

The British journal of surgery·2015

Same author

Biomaterials for craniofacial bone engineering.

Journal of dental research·2014

Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026

Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026

Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026

Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026

Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026

Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Mesenchymal cells for skeletal tissue engineering.

N J Panetta¹, D M Gupta, N Quarto

¹Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305-148, USA.

Panminerva Medica

|April 9, 2009

Summary

This summary is machine-generated.

Mesenchymal stem cell (MSC) based skeletal tissue engineering offers a promising alternative to current surgical interventions for bone defects. Future research focuses on optimizing MSC osteogenesis and scaffold development for clinical translation.

More Related Videos

Generation of Mesenchymal Stem Cells from Human Umbilical Cord Tissue and their Differentiation into the Skeletal Muscle Lineage

Generation of Mesenchymal Stem Cells from Human Umbilical Cord Tissue and their Differentiation into the Skeletal Muscle Lineage

Published on: August 31, 2022

Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation

Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation

Published on: March 19, 2013

Related Experiment Videos

Last Updated: Jun 24, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Generation of Mesenchymal Stem Cells from Human Umbilical Cord Tissue and their Differentiation into the Skeletal Muscle Lineage

Generation of Mesenchymal Stem Cells from Human Umbilical Cord Tissue and their Differentiation into the Skeletal Muscle Lineage

Published on: August 31, 2022

Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation

Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation

Published on: March 19, 2013

Area of Science:

Biomaterials Science
Regenerative Medicine
Orthopedic Surgery

Background:

Current surgical methods for skeletal defects often yield suboptimal outcomes due to limitations in tissue regeneration.
There is a significant need for advanced techniques to restore bone form and function.

Purpose of the Study:

To review the current state of mesenchymal stem cell (MSC)-based skeletal tissue engineering.
To discuss strategies for enhancing MSC osteogenesis and scaffold development for clinical applications.

Main Methods:

Review of existing literature on MSCs in skeletal tissue engineering.
Analysis of endogenous regenerative capacity studies.
Discussion of molecular manipulation and scaffold design.

Main Results:

Mesenchymal stem cells (MSCs) show potential for regenerating bone tissue.
Targeted molecular strategies and advanced scaffold design are crucial for improving MSC osteogenesis.
Further research is needed for clinical translation.

Conclusions:

Mesenchymal stem cell (MSC)-based skeletal tissue engineering represents a paradigm shift from traditional treatments.
Optimizing cell delivery and scaffold properties is key to successful clinical translation.
Continued investigation into MSC biology and biomaterials is essential for advancing bone regeneration therapies.